-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Rani Therapeutics Holdings, Inc. annual/quarterly Share-based Payment Arrangement, Expense history and growth rate from 2020 to 2023.
- Rani Therapeutics Holdings, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2022 was $4.5M, a 42.1% increase year-over-year.
- Rani Therapeutics Holdings, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2022 was $15.8M, a 30.2% decline year-over-year.
- Rani Therapeutics Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $19M, a 20.4% increase from 2022.
- Rani Therapeutics Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $15.8M, a 30.2% decline from 2021.
- Rani Therapeutics Holdings, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $22.6M.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)